查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067646

Growth Factors Plus 市場規模、佔有率和趨勢分析報告：按產品、應用和細分市場預測（2026-2033 年）

Growth Factor Plus Market Size, Share & Trends Analysis Report By Product (Serums, Creams & Gels, Injectables), By Application (Anti-Aging & Skin Rejuvenation, Scar Treatment & Wound healing), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

成長因子Plus市場概覽

全球生長因子增強劑 (GF+) 市場預計將從 2025 年的 1.257 億美元成長到 2033 年的 2.013 億美元，預計從 2026 年到 2033 年將以 6.2% 的複合年成長率成長。

這個市場涵蓋了富含生物活性生長因子的先進護膚配方，隨著消費者越來越傾向於選擇有科學依據的再生美容解決方案，該市場正在獲得強勁的發展勢頭。

生長因子是天然存在的蛋白質，能夠調節細胞生長、增殖和修復，其在傷口護理和組織再生中的作用已被廣泛研究。臨床研究表明，表皮生長因子 (EGF) 等生長因子能夠顯著促進皮膚修復並刺激膠原蛋白生成，在抗衰老和皮膚病治療中發揮至關重要的作用。這些科學證據已將 GF+ 產品確立為更廣泛的藥用化妝品市場中的高階產品。

市場成長的主要驅動力之一是消費者對經臨床驗證的護膚產品的需求日益成長。現代消費者越來越注重產品知識，他們尋求的是以皮膚病學研究為支撐的配方，而不僅僅是傳統的化妝品宣傳。研究表明，局部應用生長因子可以改善膚質、減少皺紋並加速癒合過程，從而增強了其可信度。此外，生物技術的進步使得利用生物工程和重組技術開發生長因子成為可能，提高了產品的穩定性和功效，進一步加速了其在醫療和美容護膚領域的應用。

「生長因子加強版」的優點與重要性

它能促進細胞再生和修復。

它能促進膠原蛋白和彈性蛋白的生成。

它能促進傷口護理，減輕發炎。

它可以改善膚質、膚色和色素沉著。

它有助於激活毛囊，維護頭皮健康。

它可以縮短美容手術後的恢復期。

GF+產品在術後恢復和微創美容治療的應用日益廣泛，進一步推動了市場成長。皮膚科診所和美容醫學專家擴大推薦在雷射表面置換、微針和化學換膚等療程後使用含有生長因子的精華液和乳霜。這些產品有助於加速癒合、減輕發炎並改善整體治療效果。將含GF+的產品納入專業護膚方案，顯示其臨床認可度不斷提高，並凸顯了其在彌合美容和皮膚病治療之間鴻溝方面的重要性。

消費者對高階護膚的需求日益成長，以及他們越來越願意投資於高效產品，也顯著推動了市場擴張。生長因子精華液通常被定位為奢華或醫用級護膚，正透過皮膚科診所、醫療水療中心和高階零售管道迅速走紅。例如，含有生長因子的精選產品系列在護膚平台和診所中備受矚目，突顯其在抗衰老和活膚方面的卓越功效。這種高階定位不僅提高了利潤率，也有助於品牌在競爭激烈的護膚市場中脫穎而出。

此外，媒體的影響力和美容行業的支持在加速消費者接受這些產品方面發揮著至關重要的作用。主流時尚和美容雜誌擴大將生長因子精華液作為前沿護膚方案進行報道，並著重強調其減少細紋和提升皮膚彈性等功效。這種曝光，加上皮膚科醫生和護膚專家的支持，使得生長因子產品在更廣泛的消費者群體中越來越受歡迎，已開發市場和新興市場的需求都在不斷成長。對幹細胞衍生生長因子和植物來源替代品的持續研究進一步豐富了產品線，使生長因子解決方案更容易獲得，並吸引更廣泛的受眾。隨著科學依據的不斷加強和產品創新的加速，全球生長因子+市場預計將持續成長，這主要得益於其獨特的臨床功效和美容吸引力。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：成長因素及市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 成長因子加市場分析工具

第4章：成長因子增強型市場：產品特定估算與趨勢分析

  • Growth Factor Plus 市場：產品特定波動分析
  • Growth Factor Plus 市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 血清
  • 乳霜/凝膠
  • 注射藥物
  • 其他

第5章：成長因子Plus市場：按應用分類的估算與趨勢分析

  • Growth Factor Plus 市場：基於應用的波動分析
  • Growth Factor Plus 市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 抗衰老和活膚
  • 疤痕治療和傷口護理
  • 促進頭髮生長/頭皮護理
  • 其他

第6章：成長因素及市場：依分銷管道分類的估算與趨勢分析

  • Growth Factor Plus 市場：按分銷管道分類的波動分析
  • Growth Factor Plus 市場：按分銷管道分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 離線
  • 線上

第7章：成長因子+市場：區域估算與趨勢分析

  • 區域儀錶板
  • 區域成長因子及市場波動分析
  • Growth Factor Plus 市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • SkinMedica
    • BIOEFFECT
    • Neocutis
    • Bharat BIoTech
    • Smith & Nephew
    • ZO Skin Health
    • CALECIM Professional
    • Galderma（Alastin Skincare）
    • The Ordinary
    • Perricone MD
Product Code: GVR-4-68040-909-0

Growth Factor Plus Market Summary

The global growth factor plus market size was valued at USD 125.7 million in 2025 and is projected to reach USD 201.3 million by 2033, growing at a CAGR of 6.2% from 2026 to 2033. The market encompassing advanced skincare formulations enriched with biologically active growth factors is gaining strong momentum as consumers increasingly shift toward science-backed, regenerative beauty solutions.

Growth factors, naturally occurring proteins that regulate cell growth, proliferation, and repair, have been widely studied for their roles in wound healing and tissue regeneration. Clinical research has demonstrated that growth factors such as epidermal growth factor (EGF) can significantly enhance skin repair and stimulate collagen production, making them highly relevant for anti-aging and dermatological applications. This scientific foundation has helped position GF+ products as a premium segment within the broader cosmeceuticals market.

One of the primary drivers of market growth is the rising consumer demand for clinically validated skincare products. Modern consumers are increasingly informed and are seeking formulations supported by dermatological research rather than traditional cosmetic claims. Studies have shown that topical application of growth factors can improve skin texture, reduce wrinkles, and accelerate healing processes, reinforcing their credibility. In addition, advancements in biotechnology have enabled the development of bioengineered and recombinant growth factors, improving product stability and efficacy and further fueling adoption across both medical and aesthetic skincare segments.

Advantages/Importance of Growth Factor Plus (GF+):

Stimulates cellular regeneration and repair

Enhances collagen and elastin production

Accelerates wound healing and reduces inflammation

Improves skin texture, tone, and pigmentation

Supports hair follicle stimulation and scalp health

Reduces recovery time after aesthetic procedures

The expanding use of GF+ products in post-procedure recovery and minimally invasive aesthetic treatments further fuels the market growth. Dermatology clinics and aesthetic practitioners are increasingly recommending growth factor-based serums and creams following procedures such as laser resurfacing, microneedling, and chemical peels. These products help accelerate healing, reduce inflammation, and enhance overall treatment outcomes. The integration of GF+ formulations into professional skincare protocols highlights their growing clinical acceptance and underscores their importance in bridging the gap between cosmetics and therapeutic dermatology.

The premium skincare trend and increasing consumer willingness to invest in high-performance products are also significantly contributing to market expansion. Growth factor serums, often positioned as luxury or medical-grade skincare, are gaining popularity through dermatology clinics, medspas, and high-end retail channels. For instance, curated product offerings featuring growth factors are being prominently highlighted by skincare platforms and clinics, showcasing their effectiveness in anti-aging and skin rejuvenation routines. This premium positioning not only drives higher margins but also enhances brand differentiation in a crowded skincare market.

Furthermore, media influence and beauty industry endorsements are playing a crucial role in accelerating consumer adoption. Leading fashion and beauty publications have increasingly featured growth factor serums as cutting-edge skincare solutions, often highlighting their benefits in reducing fine lines and improving skin elasticity. This visibility, combined with endorsements from dermatologists and skincare experts, is helping to normalize the use of GF+ products among a broader consumer base and boosting demand across both developed and emerging markets. Ongoing research into stem cell-derived growth factors and plant-based alternatives is further diversifying the product landscape, making GF+ solutions more accessible and appealing to a wider audience. As scientific validation continues to strengthen and product innovation accelerates, the global GF+ market is expected to witness sustained growth driven by its unique combination of clinical efficacy and cosmetic appeal.

Global Growth Factor Plus Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global growth factor plus market report based on product, application, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Serums
  • Creams & Gels
  • Injectables
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Anti-Aging & Skin Rejuvenation
  • Scar Treatment & Wound healing
  • Hair Growth / Scalp Treatment
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Distribution Channel outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Growth Factor Plus Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Growth Factor Plus Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Growth Factor Plus Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Growth Factor Plus Market: Product Movement Analysis
  • 4.3. Growth Factor Plus Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Serums
    • 4.5.1. Serums Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Creams & Gels
    • 4.6.1. Creams & Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Injectables
    • 4.7.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Growth Factor Plus Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Growth Factor Plus Market: Application Movement Analysis
  • 5.3. Growth Factor Plus Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Anti-Aging & Skin Rejuvenation
    • 5.5.1. Anti-Aging & Skin Rejuvenation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Scar Treatment & Wound healing
    • 5.6.1. Scar Treatment & Wound healing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Hair Growth / Scalp Treatment
    • 5.7.1. Hair Growth / Scalp Treatment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Growth Factor Plus Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Growth Factor Plus Market: Distribution Channel Movement Analysis
  • 6.3. Growth Factor Plus Market by Distribution Channel Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Offline
    • 6.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Online
    • 6.6.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Growth Factor Plus Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Growth Factor Plus Market Movement Analysis
  • 7.3. Growth Factor Plus Market: Regional Estimates & Trend Analysis by Product & Source
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. U.S. Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Canada Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. Mexico Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. UK Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Scenario
      • 7.5.8.5. Germany Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Scenario
      • 7.5.9.5. France Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement Scenario
      • 7.5.10.5. Italy Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement Scenario
      • 7.5.11.5. Spain Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement Scenario
      • 7.5.12.5. Denmark Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement Scenario
      • 7.5.13.5. Sweden Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement Scenario
      • 7.5.14.5. Norway Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Japan Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. China Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. India Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. South Korea Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Scenario
      • 7.6.6.5. Australia Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Scenario
      • 7.6.7.5. Thailand Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. Brazil Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Argentina Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Scenario
      • 7.8.2.5. South Africa Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Scenario
      • 7.8.3.5. Saudi Arabia Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Scenario
      • 7.8.4.5. UAE Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Scenario
      • 7.8.5.5. Kuwait Growth Factor Plus Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. SkinMedica
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. BIOEFFECT
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Neocutis
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bharat Biotech
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Smith & Nephew
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. ZO Skin Health
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. CALECIM Professional
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Galderma (Alastin Skincare)
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. The Ordinary
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Perricone MD
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6 North America Growth Factor Plus Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 10 U.S. Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 13 Canada Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 Canada Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 16 Mexico Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19 Europe Growth Factor Plus Market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Europe Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 23 Germany Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Germany Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 25 Germany Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 26 Spain Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Spain Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Spain Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 UK Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 30 UK Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 32 Italy Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 34 Italy Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 35 France Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 France Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 38 Dernmark Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Dernmark Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 Dernmark Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41 Sweden Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Sweden Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 44 Norway Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 46 Norway Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Growth Factor Plus Market, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 51 India Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 India Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 53 India Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 54 Japan Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Japan Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Japan Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 57 China Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 58 China Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 59 China Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 60 Australia Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 61 Australia Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 62 Australia Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 63 South Korea Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 South Korea Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 South Korea Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 66 Thailand Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 67 Thailand Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Thailand Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 69 Latin America Growth Factor Plus Market, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 71 Latin America Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 72 Latin America Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 73 Argentina Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 74 Argentina Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 75 Argentina Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 76 Brazil Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Brazil Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 78 Brazil Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Growth Factor Plus Market, by Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 South Africa Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 87 South Africa Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 88 South Africa Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 89 UAE Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 90 UAE Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 91 UAE Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Growth Factor Plus Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Growth Factor Plus Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Growth Factor Plus Market, by Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Growth Factor Plus market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Growth factor plus market, product outlook key takeaways (USD Million)
  • Fig. 12 Growth factor plus market: product movement analysis, 2025 & 2033 (USD Million)
  • Fig. 13 Serums market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Creams & gels market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Injectables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Growth factor plus market, application outlook key takeaways (USD Million)
  • Fig. 18 Growth factor plus market: application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 19 Anti-aging & skin rejuvenation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Scar treatment & wound healing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Hair growth / scalp treatment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Growth factor plus market, distribution channel outlook key takeaways (USD Million)
  • Fig. 24 Growth factor plus market: distribution channel movement analysis, 2025 & 2033 (USD Million)
  • Fig. 25 Offline market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Online market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Growth factor plus market, regional key takeaways (USD Million)
  • Fig. 28 Growth factor plus market regional outlook, 2025 & 2033 (USD Million)
  • Fig. 29 North America growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 US growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Canada growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Europe growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 UK growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Germany growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 France growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Italy growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Spain growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Norway growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Paciifc growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Japan growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 China growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 India growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Australia growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 South Korea growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Middle East & Africa growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 UAE growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait growth factor plus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 List of key emerging company's/indication disruptors/innovators